The goal of pharmacovigilance is to detect, monitor, characterize and prevent adverse drug
events (ADEs) with pharmaceutical products. This article is a comprehensive structured …

Drug–drug interactions (DDIs) constitute an important concern in drug development and
postmarketing pharmacovigilance. They are considered the cause of many adverse drug …

The identification of drug-target interactions has great significance for pharmaceutical
scientific research. Since traditional experimental methods identifying drug-target …

Identification of adverse drug reactions (ADRs) during the post-marketing phase is one of
the most important goals of drug safety surveillance. Spontaneous reporting systems (SRS) …

Background In the era of information overload, natural language processing (NLP)
techniques are increasingly needed to support advanced biomedical information …

Therapeutic activities of drugs are often influenced by co-administration of drugs that may
cause inevitable drug-drug interactions (DDIs) and inadvertent side effects. Prediction and …

Drug-drug interaction (DDI) is a change in the effect of a drug when patient takes another
drug. Characterizing DDIs is extremely important to avoid potential adverse drug reactions …

Introduction The authors of this work propose an unsupervised machine learning model that
has the ability to identify real-world latent infectious diseases by mining social media data. In …

Objective Emergency department (ED) overcrowding is a serious issue for hospitals. Early
information on short-term inward bed demand from patients receiving care at the ED may …

Background Current approaches to identifying drug-drug interactions (DDIs), include safety
studies during drug development and post-marketing surveillance after approval, offer …